Huang Tyler C, Chu Gaosheng, Singh Sushma
J-Star Research, Inc., A Porton Company, 3001 Hadley Road, South Plainfield, NJ 07080, USA.
J-Star Research, Inc., A Porton Company, 3001 Hadley Road, South Plainfield, NJ 07080, USA.
J Pharm Biomed Anal. 2023 Oct 25;235:115613. doi: 10.1016/j.jpba.2023.115613. Epub 2023 Jul 31.
This work was motivated by the United States Pharmacopeia monograph modernization initiative and European directorate for the quality of medicines and healthcare. An out-of-specification (OOS) occurrence prompted OOS investigations for the cGMP (cGMP refers to the Current Good Manufacturing Practice regulations enforced by the FDA) release testing of residual ethylene oxide in polyethylene glycol (PEG) according to the standards detailed within the United States Pharmacopeia/National Formulary (USP-NF) for polyethylene glycol, and the European Pharmacopoeia (Ph. Eur.) for macrogols. During the OOS root cause investigations, we observed a PEG degradant and identified it as methyl formate, which co-elutes with ethylene oxide using the GC (gas chromatography) methods published in current USP-NF and Ph. Eur. for PEGs. To address this, a novel method utilizing static headspace gas chromatography with flame ionization detection (HS-GC-FID) was developed to test various grades of PEGs for the presence of residual ethylene oxide, along with other process related impurities and degradation products. With this new method, ethylene oxide, a known genotoxic impurity and IARC (International Agency for Research on Cancer) Class 1 human carcinogen, can be well resolved from methyl formate, a newly identified and comparatively innocuous degradant derived from PEG. The currently available official compendial methods are unable to separate the specific impurities in PEGs. However, the new GC method presented in this paper has been shown to have a high and unique selectivity, allowing for baseline separations (chromatographic resolutions greater than 1.5) of all related impurities in PEGs, which is a challenging task. Additionally, this method has been found to be stability-indicating based on a forced degradation study. During stress stability study of PEGs involving acid, alkali, heat, light, and oxidation, some other PEG degradants, including formaldehyde, were identified. It is possible that formaldehyde undergoes a disproportionation reaction known as the Cannizzaro reaction, leading to the formation of formic acid and methanol. The formic acid then undergoes an esterification reaction with methanol to produce methyl formate. To the best of our knowledge, this is the first stability-indicating HS-GC-FID method that accomplishes this separation in a single run, and it was successfully validated as per ICH (the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use) guidelines. Therefore, this method is suitable for the conduct of cGMP batch release and stability testing of PEGs in regulated quality control (QC) laboratories.
这项工作是受美国药典专论现代化倡议以及欧洲药品和医疗保健质量管理局的推动。一次超标(OOS)事件促使对聚乙二醇(PEG)中残留环氧乙烷的cGMP(cGMP指美国食品药品监督管理局强制执行的现行药品生产质量管理规范)放行检测展开OOS调查,检测依据美国药典/国家处方集(USP-NF)中关于聚乙二醇的详细标准以及欧洲药典(Ph. Eur.)中关于聚乙二醇的标准进行。在OOS根本原因调查过程中,我们观察到一种PEG降解产物,并将其鉴定为甲酸甲酯,它在现行USP-NF和Ph. Eur.中公布用于PEG的气相色谱(GC)方法下与环氧乙烷共洗脱。为解决这一问题,开发了一种利用带有火焰离子化检测的静态顶空气相色谱法(HS-GC-FID)的新方法,用于检测各种等级PEG中残留环氧乙烷以及其他与工艺相关的杂质和降解产物的存在情况。通过这种新方法,环氧乙烷这种已知的遗传毒性杂质和国际癌症研究机构(IARC)1类人类致癌物能够与甲酸甲酯很好地分离,甲酸甲酯是一种新鉴定出的且相对无害的PEG衍生降解产物。目前可用的官方药典方法无法分离PEG中的特定杂质。然而,本文提出的新GC方法已显示出具有高且独特的选择性,能够实现PEG中所有相关杂质的基线分离(色谱分辨率大于1.5),这是一项具有挑战性的任务。此外,基于强制降解研究,该方法已被发现具有稳定性指示作用。在涉及酸、碱、热、光和氧化的PEG应力稳定性研究中,鉴定出了一些其他PEG降解产物,包括甲醛。甲醛可能发生一种称为坎尼扎罗反应的歧化反应,导致形成甲酸和甲醇。然后甲酸与甲醇发生酯化反应生成甲酸甲酯。据我们所知,这是第一种能够在一次运行中完成这种分离的稳定性指示HS-GC-FID方法,并且已按照国际人用药品注册技术协调会(ICH)指南成功验证。因此,该方法适用于在受监管的质量控制(QC)实验室中对PEG进行cGMP批次放行和稳定性测试。